Neurologia
Estudo descobre que 96,1% dos pacientes se recuperaram da anosmia 1 ano depois do diagnóstico de COVID-19.
28 Jun, 2021 | 10:37hClinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis – JAMA Network Open
Comentário: Did Covid-19 take your taste and smell? Here’s when they may return – CNN E Lost Sense of Smell Returns for Almost All COVID Survivors – HealthDay
“Long Covid”: estudo mostra que metade dos adultos jovens com COVID-19 apresentaram sintomas 6 meses depois da doença.
25 Jun, 2021 | 10:45hEstudo original: Long COVID in a prospective cohort of home-isolated patients – Nature Medicine
Comentário no Twitter
Analysis of a prospectively enrolled cohort of patients with #SARSCoV2 infections reveals a high proportion who experienced #LongCovid symptoms at 6 months, despite being relatively young and having only mild to moderate acute #COVID19 symptoms https://t.co/fuW2QpfJog
— Nature Medicine (@NatureMedicine) June 23, 2021
Consenso sobre concussões relaticionadas ao esporte (sport-related concussion – SRC) – “A evidência atual sugere que repouso estrito após SRC retarda a recuperação e aumenta a probabilidade de sintomas prolongados.”
25 Jun, 2021 | 10:35hComunicado de imprensa: Strict Rest Slows Recovery after Sports-Related Concussions – American College of Sports Medicine
Estudo de coorte | Não foi encontrada nenhuma associação entre terapia com estatinas e declínio cognitivo ou incidência de demência em idosos.
23 Jun, 2021 | 10:52hComentários: Statin Therapy Not Associated With Cognitive Decline, Dementia in Older Adults, Study Says – American College of Cardiology E Effect of Statins on Cognitive Decline and Dementia in Older Adults – American College of Cardiology
Recomendações do consenso 2021 MAGNIMS–CMSC–NAIMS para o uso de ressonância magnética em pacientes com esclerose múltipla.
22 Jun, 2021 | 09:06h2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis – The Lancet Neurology (necessário cadastro gratuito)
Comentário no Twitter
ONLINE FIRST: The 2021 MAGNIMS–CMSC–NAIMS international consensus recommendations on MRI in patients with multiple sclerosis provide updated guidance on how and when to use MRI for diagnosis, prognosis, and treatment monitoring of multiple sclerosishttps://t.co/bLnRo40tgw
— The Lancet Neurology (@TheLancetNeuro) June 15, 2021
Comentário sobre estudo | História da hipotermia na parada cardíaca, 2002-2021 (RIP).
18 Jun, 2021 | 10:29hA history of hypothermia for cardiac arrest, 2002-2021 (RIP) – PulmCrit
Estudo original: RCT: In patients with coma after out-of-hospital cardiac arrest, targeted hypothermia did not improve outcomes.
Comentário no Twitter
A history of hypothermia for cardiac arrest, 2002-2021 (RIP)🪦
🥶2002 studies supporting hypothermia were weak
🥶robust studies refute benefit (TTM1 & TTM2)
🥶growing evidence of iatrogenic harm
🥶post-arrest hypothermia should be restricted to within RCTshttps://t.co/GZbpgHXWoD pic.twitter.com/ILUAiqqLQl— 𝙟𝙤𝙨𝙝 𝙛𝙖𝙧𝙠𝙖𝙨 💊 (@PulmCrit) June 17, 2021
M-A | Tratamentos agudos para enxaqueca episódica em adultos.
18 Jun, 2021 | 10:28hAcute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis – JAMA (gratuito por tempo limitado)
Editorial: Acute Treatment for Migraine: Contemporary Treatments and Future Directions (gratuito por tempo limitado)
Comentário no Twitter (fio – clique para saber mais)
Science marches breathlessly forward – or, at least tries to expand its indication.
Anti–calcitonin gene-related peptide antibody infusion, again, vs. placebo.
— Ryan Radecki, MD MS (@emlitofnote) June 17, 2021
Estudo randomizado | Efeitos do eptinezumabe intravenoso vs. placebo sobre a cefaleia e outros sintomas quando administrado no início de uma crise de enxaqueca.
18 Jun, 2021 | 10:27hEffects of Intraven.ous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Editorial: Acute Treatment for Migraine: Contemporary Treatments and Future Directions (gratuito por tempo limitado)
Comentário: Migraine Prevention Drug Eptinezumab Shows Efficacy in Treating Acute Attacks – Physician’s Weekly
Comentário no Twitter (fio – clique para saber mais)
Science marches breathlessly forward – or, at least tries to expand its indication.
Anti–calcitonin gene-related peptide antibody infusion, again, vs. placebo.
— Ryan Radecki, MD MS (@emlitofnote) June 17, 2021
Estudo randomizado | Em paciente em coma após parada cardíaca fora do ambiente hospitalar, a hipotermia induzida não melhorou os desfechos.
17 Jun, 2021 | 10:56hComunicado de imprensa: Induced hypothermia after cardiac arrest did not improve survival – Lund University
Infográfico: The TTM2 Trial – CanadianEM
Comentário: Hypothermia or Normothermia after Cardiac Arrest – NEJM Resident 360
Vídeo: TTM2 Results Presentation Livestream – Critical Care Reviews
Comentário no Twitter (fio – clique para saber mais)
The #TTM2trial was published today in the @NEJM https://t.co/jccLB1MO64
Here’s a summary of what we did, what I think the trial means, and what next.@ttm2trial @nielsen_niklas @CritCareReviews @NEJM— Paul Young (@DogICUma) June 16, 2021
Estudo randomizado | Estimulação nervosa periférica percutânea (neuromodulação) para dor pós-cirúrgica.
16 Jun, 2021 | 10:47hComentário: Peripheral Nerve Stimulation May Cut Pain After Orthopedic Surgery – HealthDay